[1]BioorganicandMedicinalChemistryLetters,2000,vol.10,p.2825-2828
[1]CurrentPatentAssignee:1CBIO-WO2022/91048,2022,A1Locationinpatent:Paragraph251;254
[2]CurrentPatentAssignee:1CBIO-WO2022/91048,2022,A1Locationinpatent:Paragraph251;254
132118-45-7
203626-39-5
75896-68-3
68500-37-8
73387-74-3
1167056-82-7
721406-67-3 | 2-((2-Oxo-2-(pyrrolidin-1-yl)ethyl)thio)benzoic acid | AA00FC1F | MFCD03949353
685-89-2 | METHYL-2-BROMO-6-CHLOROBENZOATE | AA00FC6O | MFCD03789160
72468-94-1 | 1-Chloro-3-isopropoxypropane | AA00FCGP | MFCD09753651
68937-55-3 | Polysiloxanes, di-Me,3-hydroxypropyl Me, ethoxylated propoxylated | AA00FCNB | MFCD00240066
7271-11-6 | 4-(4-Bromophenyl)-4,5,6,7-tetrahydro-3h-imidazo[4,5-c]pyridine | AA00FCZ1 | MFCD09749762
68571-74-4 | 3-Methylisoxazolo[5,4-d]pyrimidin-4(5h)-one | AA00FD2X | MFCD14280279
66108-85-8 | 1-Methyl-5-nitro-2,3-dihydro-1h-1,3-benzodiazol-2-one | AA00FD7F | MFCD18157683
67372-69-4 | 6,7-DeMethylene-6,7-dehydro Drospirenone | AA00FDEZ | MFCD18839213
690996-26-0 | 15,16-Dehydro Estradiol 3-Benzyl Ether | AA00FDOM | MFCD28899064
71507-21-6 | (17beta)-4,17-dimethylandrosta-2,4-dieno[2,3-d]isoxazol-17-ol | AA00FDV9